These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 28706293)
1. Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance. Klameth L; Rath B; Hochmaier M; Moser D; Redl M; Mungenast F; Gelles K; Ulsperger E; Zeillinger R; Hamilton G Sci Rep; 2017 Jul; 7(1):5337. PubMed ID: 28706293 [TBL] [Abstract][Full Text] [Related]
2. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines. Hochmair M; Rath B; Klameth L; Ulsperger E; Weinlinger C; Fazekas A; Plangger A; Zeillinger R; Hamilton G Invest New Drugs; 2020 Aug; 38(4):946-955. PubMed ID: 31446534 [TBL] [Abstract][Full Text] [Related]
3. Overcoming resistance in small-cell lung cancer. Hamilton G; Hochmair MJ; Stickler S Expert Rev Respir Med; 2024 Aug; 18(8):569-580. PubMed ID: 39099310 [TBL] [Abstract][Full Text] [Related]
4. Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells. Stickler S; Rath B; Hochmair M; Lang C; Weigl L; Hamilton G Oncol Res; 2023; 31(1):13-22. PubMed ID: 37303738 [TBL] [Abstract][Full Text] [Related]
5. Metastasis: Circulating Tumor Cells in Small Cell Lung Cancer. Hamilton G; Moser D; Hochmair M Trends Cancer; 2016 Apr; 2(4):159-160. PubMed ID: 28741567 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer. Hamilton G; Rath B Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677 [TBL] [Abstract][Full Text] [Related]
7. Role of circulating tumor cell spheroids in drug resistance. Hamilton G; Rath B Cancer Drug Resist; 2019; 2(3):762-772. PubMed ID: 35582592 [TBL] [Abstract][Full Text] [Related]
8. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype. Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626 [TBL] [Abstract][Full Text] [Related]
9. Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines. Rath B; Hochmair M; Plangger A; Hamilton G Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30322180 [TBL] [Abstract][Full Text] [Related]
10. Significance of circulating tumor cells in lung cancer: a narrative review. Hamilton G; Rath B; Stickler S Transl Lung Cancer Res; 2023 Apr; 12(4):877-894. PubMed ID: 37197632 [TBL] [Abstract][Full Text] [Related]
11. Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pair. Rath B; Plangger A; Krenbek D; Hochmair M; Stickler S; Tretter V; Hamilton G Anticancer Drugs; 2022 Mar; 33(3):300-307. PubMed ID: 34924498 [TBL] [Abstract][Full Text] [Related]
12. Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines. Rath B; Klameth L; Plangger A; Hochmair M; Ulsperger E; Huk I; Zeillinger R; Hamilton G Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669448 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. Messaritakis I; Politaki E; Kotsakis A; Dermitzaki EK; Koinis F; Lagoudaki E; Koutsopoulos A; Kallergi G; Souglakos J; Georgoulias V PLoS One; 2017; 12(7):e0181211. PubMed ID: 28719656 [TBL] [Abstract][Full Text] [Related]
14. Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells. Hamilton G; Rath B; Holzer S; Hochmair M Transl Lung Cancer Res; 2016 Feb; 5(1):71-7. PubMed ID: 26958494 [TBL] [Abstract][Full Text] [Related]
15. Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation. Rath B; Plangger A; Klameth L; Hochmair M; Ulsperger E; Boeckx B; Neumayer C; Hamilton G Explor Target Antitumor Ther; 2023; 4(2):355-365. PubMed ID: 37205313 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients. Wang X; Ma K; Wang Y; He H; Hu JF; Li W Arch Med Res; 2016 Aug; 47(6):454-459. PubMed ID: 27986125 [TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer. Pore M; Meijer C; de Bock GH; Boersma-van Ek W; Terstappen LW; Groen HJ; Timens W; Kruyt FA; Hiltermann TJ Clin Lung Cancer; 2016 Nov; 17(6):535-542. PubMed ID: 27363902 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462 [TBL] [Abstract][Full Text] [Related]
19. Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer. Bryant JL; Gieling RG; Meredith SL; Allen TJ; Walker L; Telfer BA; Supuran CT; Williams KJ; White A Int J Cancer; 2018 Jan; 142(1):191-201. PubMed ID: 28905987 [TBL] [Abstract][Full Text] [Related]
20. Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib. Messaritakis I; Politaki E; Koinis F; Stoltidis D; Apostolaki S; Plataki M; Dermitzaki EK; Georgoulias V; Kotsakis A Sci Rep; 2018 Feb; 8(1):2238. PubMed ID: 29396560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]